Deciphera is a biopharmaceutical company focused on discovering, developing, and commercializing important new medicines to improve the lives of people with cancer. We are leveraging our proprietary switch-control kinase inhibitor platform and deep expertise in kinase biology to develop a broad portfolio of innovative medicines. For more information, visit www.deciphera.com.
View Top Employees from Deciphera PharmaceuticalsWebsite | http://www.deciphera.com |
Ticker | DCPH |
Revenue | $121.9 million |
Funding | $1 billion |
Employees | 398 (398 on RocketReach) |
Founded | 2003 |
Address | 200 Smith St, Waltham, Massachusetts 02451, US |
Phone | (781) 209-6400 |
Fax | (785) 830-2150 |
Technologies |
JavaScript,
HTML,
reCAPTCHA
+34 more
(view full list)
|
Industry | Pharmaceutical Manufacturing, Pharmaceuticals, Medical, Drug Discovery, Healthcare, Health Care, Other Pharmaceuticals and Biotechnology, Pharmaceutical, Therapeutics |
Web Rank | 3 Million |
Keywords | Biopharmaceuticals, Innovative Medicine, Cancer Treatment, Personalized Medical Care, Targeted Cancer Therapies |
Competitors | Clovis Oncology, G1 Therapeutics, Inc., Karyopharm Therapeutics Inc., Lengo Therapeutics, Mirati Therapeutics Inc |
SIC | SIC Code 87 Companies, SIC Code 873 Companies, SIC Code 28 Companies, SIC Code 283 Companies |
NAICS | NAICS Code 3254 Companies, NAICS Code 325 Companies, NAICS Code 32 Companies, NAICS Code 325413 Companies, NAICS Code 32541 Companies |
Looking for a particular Deciphera Pharmaceuticals employee's phone or email?
The Deciphera Pharmaceuticals annual revenue was $121.9 million in 2024.
John Hebert is the Vice President, Corporate Development and Alliance Management of Deciphera Pharmaceuticals.
398 people are employed at Deciphera Pharmaceuticals.
Deciphera Pharmaceuticals is based in Waltham, Massachusetts.
The NAICS codes for Deciphera Pharmaceuticals are [3254, 325, 32, 325413, 32541].
The SIC codes for Deciphera Pharmaceuticals are [87, 873, 28, 283].